Fludrocortisone

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Synthetic mineralocorticoid.

Half-lifeThis section has been translated automatically.

1 h or 4,8 h (metabolites).

IndicationThis section has been translated automatically.

Adrenogenital syndrome, Addison's disease, adrenocortical insufficiency.

Limited indicationThis section has been translated automatically.

Pregnancy, heart failure.

Dosage and method of useThis section has been translated automatically.

0.05-0.2 mg/day, simultaneously glucocorticoid substitution adapted to the daily rhythm, e.g. 15-30 mg hydrocortisone.

Undesirable effectsThis section has been translated automatically.

Systemic application: headache, dizziness, edema, heart failure, metabolic alkalosis, hypokalemia, sodium retention, arthralgias, allergic skin reactions.

InteractionsThis section has been translated automatically.

Laxatives, saluretics and thiazide diuretics lead to increased hypokalemia.

ContraindicationThis section has been translated automatically.

Advanced atherosclerosis, hypertension.

PreparationsThis section has been translated automatically.

Astonin-H

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer